The new ad buy from PhRMA features the recurring “Middleman” character representing pharmaceutical benefit managers, and argues that “Congress should make sure savings” from drug rebate ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

I have spent my career fighting for the hardworking people of our state—especially those who need our support the most.

President Biden and Vice President Kamala Harris pretended to be anti-pharma but have taken over $10 million combined from ...

Operator Good afternoon, ladies and gentlemen, and welcome to the Inovio third quarter 2024 financial results conference call ...

The new platform services subscription contract with a top six U.S. pharma client marks a pivotal shift in Dario's pharma ...

EQS-News: SynBiotic SE / Key word (s): Miscellaneous In full bloom: WEECO Pharma boosts SYNBIOTIC's sales 14.11.2024 / 13:30 CET/CEST The issuer is solely responsible for the content of this ...

YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in Q3– TransCon CNP ...

Adults with hypoparathyroidism treated with TransCon PTH in the phase 3 PaTHway open-label trial extension demonstrated ...